Limb-girdle muscular dystrophy 2C, gamma-sarcoglycan deficiency (Q86054): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:25, 15 August 2026
Autosomal recessive limb-girdle muscular dystrophy type 2C, or gamma-sarcoglycanopathy is a limb girdle muscular dystrophy (LGMD), a group of disorders characterised by progressive muscle weakness predominantly or primarily involving the pelvic or shoulder girdle musculature, and is characterised by scapular winging and calf hypertrophy with onset before 10 years of age. Cardiac involvement occurs in about 20% of cases.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_440038386 |
||
| English | Limb-girdle muscular dystrophy 2C, gamma-sarcoglycan deficiency |
Autosomal recessive limb-girdle muscular dystrophy type 2C, or gamma-sarcoglycanopathy is a limb girdle muscular dystrophy (LGMD), a group of disorders characterised by progressive muscle weakness predominantly or primarily involving the pelvic or shoulder girdle musculature, and is characterised by scapular winging and calf hypertrophy with onset before 10 years of age. Cardiac involvement occurs in about 20% of cases. |
Statements
CID11:ID_440038386
0 references
dki-india-ID_440038386
0 references
Concluído
0 references
13 August 2026
0 references
